Novel Biologics

PreEMT technology enables the development of novel biologics by facilitating the economical production of proteins at clinical and commercial scale. Protein therapeutics may fail in development due to the inability to produce sufficient material for large animal studies or to establish a commercially viable manufacturing process. Utilizing its PreEMT technology, BaroFold provides companies with a more efficient process for difficult-to-manufacture protein therapeutics that would not be commercially viable under other methods.